-
Je něco špatně v tomto záznamu ?
Salivary Gland Secretory Carcinoma: Clinicopathologic and Genetic Characteristics of 215 Cases and Proposal for a Grading System
M. Baněčková, LDR. Thompson, MD. Hyrcza, T. Vaněček, A. Agaimy, J. Laco, RHW. Simpson, S. Di Palma, TM. Stevens, L. Brcic, A. Etebarian, K. Dimnik, H. Majewska, I. Stárek, E. O'Regan, T. Salviato, T. Helliwell, M. Horáková, W. Biernat, T. Onyuma,...
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- antigen Ki-67 MeSH
- fúzní onkogenní proteiny genetika metabolismus MeSH
- lidé MeSH
- lokální recidiva nádoru genetika MeSH
- nádorové biomarkery genetika metabolismus MeSH
- nádory slinných žláz * patologie MeSH
- nekróza MeSH
- retrospektivní studie MeSH
- sekreční karcinom mamárního typu * genetika MeSH
- slinné žlázy metabolismus patologie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Salivary gland secretory carcinoma (SC), previously mammary analog SC, is a low-grade malignancy characterized by well-defined morphology and an immunohistochemical and genetic profile identical to SC of the breast. Translocation t(12;15)(p13;q25) resulting in the ETV6 :: NTRK3 gene fusion is a characteristic feature of SC along with S100 protein and mammaglobin immunopositivity. The spectrum of genetic alterations for SC continues to evolve. The aim of this retrospective study was to collect data of salivary gland SCs and to correlate their histologic, immunohistochemical, and molecular genetic data with clinical behavior and long-term follow-up. In this large retrospective study, we aimed to establish a histologic grading scheme and scoring system. A total of 215 cases of salivary gland SCs diagnosed between 1994 and 2021 were obtained from the tumor registries of the authors. Eighty cases were originally diagnosed as something other than SC, most frequently acinic cell carcinoma. Lymph node metastases were identified in 17.1% (20/117 cases with available data), with distant metastasis in 5.1% (6/117). Disease recurrence was seen in 15% (n=17/113 cases with available data). The molecular genetic profile showed ETV6 :: NTRK3 gene fusion in 95.4%, including 1 case with a dual fusion of ETV6 :: NTRK3 and MYB :: SMR3B . Less frequent fusion transcripts included ETV6 :: RET (n=12) and VIM :: RET (n=1). A 3-tiered grading scheme using 6 pathologic parameters (prevailing architecture, pleomorphism, tumor necrosis, perineural invasion (PNI), lymphovascular invasion (LVI), and mitotic count and/or Ki-67 labeling index) was applied. Grade 1 histology was observed in 44.7% (n=96), grade 2 in 41.9% (n=90), and grade 3 in 13.5% (n=29) of cases. Compared with low-grade and intermediate-grade SC, high-grade tumors were associated with a solid architecture, more prominent hyalinization, infiltrative tumor borders, nuclear pleomorphism, presence of PNI and/or LVI, and Ki-67 proliferative index >30%. High-grade transformation, a subset of grade 2 or 3 tumors, seen in 8.8% (n=19), was defined as an abrupt transformation of conventional SC into high-grade morphology, sheet-like growth, and a tumor lacking distinctive features of SC. Both overall survival and disease-free survival (5 and 10 y) were negatively affected by tumor grade, stage, and TNM status (each P <0.0001). SC is a low-grade malignancy with predominantly solid-microcystic growth patterns, driven by a gene fusion, most commonly ETV6 :: NTRK3 . There is a low risk for local recurrence and a good overall long-term survival, with a low risk for distant metastasis but a higher risk for locoregional lymph node metastasis. The presence of tumor necrosis, hyalinization, PNI and/or LVI, and positive resection margins correlate with higher tumor grade, less favorable prognosis, and increased mortality. The statistical results allowed us to design a 3-tiered grading system for salivary SC.
Department of Cellular Pathology University of Liverpool Liverpool UK
Department of Pathology Charles University Faculty of Medicine in Plzen
Department of Pathology Kenyatta National Hospital Nairobi Kenya
Department of Pathology Medical University of Gdansk Gdansk Poland
Department of Pathology University of Alabama at Birmingham Birmingham AL
Department of Pathology Warmia and Mazury University Olsztyn
Diagnostic and Research Institute of Pathology Medical University of Graz Graz Austria
Head and Neck Pathology Consultations Woodland Hills CA
Institute of Biomedicine Pathology University of Turku and Turku University Hospital Turku Finland
Institute of Pathology Faculty of Medicine University of Ljubljana Ljubljana Slovenia
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23011204
- 003
- CZ-PrNML
- 005
- 20230801132856.0
- 007
- ta
- 008
- 230718s2023 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1097/PAS.0000000000002043 $2 doi
- 035 __
- $a (PubMed)37070739
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Baněčková, Martina $u Department of Pathology, Charles University, Faculty of Medicine in Plzen $u Bioptic Laboratory Ltd Plzen $1 https://orcid.org/0000000258295572
- 245 10
- $a Salivary Gland Secretory Carcinoma: Clinicopathologic and Genetic Characteristics of 215 Cases and Proposal for a Grading System / $c M. Baněčková, LDR. Thompson, MD. Hyrcza, T. Vaněček, A. Agaimy, J. Laco, RHW. Simpson, S. Di Palma, TM. Stevens, L. Brcic, A. Etebarian, K. Dimnik, H. Majewska, I. Stárek, E. O'Regan, T. Salviato, T. Helliwell, M. Horáková, W. Biernat, T. Onyuma, M. Michal, I. Leivo, A. Skalova
- 520 9_
- $a Salivary gland secretory carcinoma (SC), previously mammary analog SC, is a low-grade malignancy characterized by well-defined morphology and an immunohistochemical and genetic profile identical to SC of the breast. Translocation t(12;15)(p13;q25) resulting in the ETV6 :: NTRK3 gene fusion is a characteristic feature of SC along with S100 protein and mammaglobin immunopositivity. The spectrum of genetic alterations for SC continues to evolve. The aim of this retrospective study was to collect data of salivary gland SCs and to correlate their histologic, immunohistochemical, and molecular genetic data with clinical behavior and long-term follow-up. In this large retrospective study, we aimed to establish a histologic grading scheme and scoring system. A total of 215 cases of salivary gland SCs diagnosed between 1994 and 2021 were obtained from the tumor registries of the authors. Eighty cases were originally diagnosed as something other than SC, most frequently acinic cell carcinoma. Lymph node metastases were identified in 17.1% (20/117 cases with available data), with distant metastasis in 5.1% (6/117). Disease recurrence was seen in 15% (n=17/113 cases with available data). The molecular genetic profile showed ETV6 :: NTRK3 gene fusion in 95.4%, including 1 case with a dual fusion of ETV6 :: NTRK3 and MYB :: SMR3B . Less frequent fusion transcripts included ETV6 :: RET (n=12) and VIM :: RET (n=1). A 3-tiered grading scheme using 6 pathologic parameters (prevailing architecture, pleomorphism, tumor necrosis, perineural invasion (PNI), lymphovascular invasion (LVI), and mitotic count and/or Ki-67 labeling index) was applied. Grade 1 histology was observed in 44.7% (n=96), grade 2 in 41.9% (n=90), and grade 3 in 13.5% (n=29) of cases. Compared with low-grade and intermediate-grade SC, high-grade tumors were associated with a solid architecture, more prominent hyalinization, infiltrative tumor borders, nuclear pleomorphism, presence of PNI and/or LVI, and Ki-67 proliferative index >30%. High-grade transformation, a subset of grade 2 or 3 tumors, seen in 8.8% (n=19), was defined as an abrupt transformation of conventional SC into high-grade morphology, sheet-like growth, and a tumor lacking distinctive features of SC. Both overall survival and disease-free survival (5 and 10 y) were negatively affected by tumor grade, stage, and TNM status (each P <0.0001). SC is a low-grade malignancy with predominantly solid-microcystic growth patterns, driven by a gene fusion, most commonly ETV6 :: NTRK3 . There is a low risk for local recurrence and a good overall long-term survival, with a low risk for distant metastasis but a higher risk for locoregional lymph node metastasis. The presence of tumor necrosis, hyalinization, PNI and/or LVI, and positive resection margins correlate with higher tumor grade, less favorable prognosis, and increased mortality. The statistical results allowed us to design a 3-tiered grading system for salivary SC.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a antigen Ki-67 $7 D019394
- 650 _2
- $a fúzní onkogenní proteiny $x genetika $x metabolismus $7 D015514
- 650 _2
- $a nádorové biomarkery $x genetika $x metabolismus $7 D014408
- 650 _2
- $a lokální recidiva nádoru $x genetika $7 D009364
- 650 12
- $a nádory slinných žláz $x patologie $7 D012468
- 650 12
- $a sekreční karcinom mamárního typu $x genetika $7 D000069295
- 650 _2
- $a slinné žlázy $x metabolismus $x patologie $7 D012469
- 650 _2
- $a nekróza $7 D009336
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Thompson, Lester D R $u Head and Neck Pathology Consultations, Woodland Hills, CA
- 700 1_
- $a Hyrcza, Martin D $u Department of Pathology and Laboratory Medicine, University of Calgary, Arnie Charbonneau Cancer Institute
- 700 1_
- $a Vaněček, Tomáš $u Molecular Genetic Laboratory, Bioptic Laboratory Ltd, Plzen
- 700 1_
- $a Agaimy, Abbas $u Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Comprehensive Cancer Center (CCC) Erlangen-EMN, Erlangen, Germany
- 700 1_
- $a Laco, Jan $u The Fingerland Department of Pathology, Charles University, Faculty of Medicine and University Hospital Hradec Kralove, Hradec Kralove
- 700 1_
- $a Simpson, Roderick H W $u Department of Pathology and Laboratory Medicine, University of Calgary, Calgary Laboratory Services, Foothills Medical Centre, Calgary, AB, Canada
- 700 1_
- $a Di Palma, Silvana $u Division of Clinical Medicine, Department of Histopathology, University of Surrey, Royal Surrey County Hospital, Guildford, Surrey
- 700 1_
- $a Stevens, Todd M $u Department of Pathology, University of Alabama at Birmingham, Birmingham, AL
- 700 1_
- $a Brcic, Luka $u Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria
- 700 1_
- $a Etebarian, Arghavan $u Department of Oral and Maxillofacial Pathology, School of Dentistry, Alborz University of Medical Sciences, Karaj, Iran
- 700 1_
- $a Dimnik, Katarina $u Institute of Pathology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
- 700 1_
- $a Majewska, Hanna $u Department of Pathology, Warmia and Mazury University, Olsztyn
- 700 1_
- $a Stárek, Ivo $u Department of Otorhinolaryngology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic
- 700 1_
- $a O'Regan, Esther $u Department of Histopathology, St. James's Hospital & Dublin Dental Hospital, Trinity College Dublin, Dublin, Ireland
- 700 1_
- $a Salviato, Tiziana $u Division of Pathology, Department of Medical and Surgical Sciences for Children & Adults, University-Hospital of Modena and Reggio Emilia, Modena, Italy
- 700 1_
- $a Helliwell, Tim $u Department of Cellular Pathology, University of Liverpool, Liverpool, UK
- 700 1_
- $a Horáková, Markéta $u Department of Pathology, Charles University, Faculty of Medicine in Plzen $u Bioptic Laboratory Ltd Plzen
- 700 1_
- $a Biernat, Wojciech $u Department of Pathology, Medical University of Gdansk, Gdansk, Poland
- 700 1_
- $a Onyuma, Timothy $u Department of Pathology, Kenyatta National Hospital, Nairobi, Kenya
- 700 1_
- $a Michal, Michal $u Department of Pathology, Charles University, Faculty of Medicine in Plzen $u Bioptic Laboratory Ltd Plzen
- 700 1_
- $a Leivo, Ilmo $u Institute of Biomedicine, Pathology, University of Turku and Turku University Hospital, Turku, Finland
- 700 1_
- $a Skalova, Alena $u Department of Pathology, Charles University, Faculty of Medicine in Plzen $u Bioptic Laboratory Ltd Plzen
- 773 0_
- $w MED00000304 $t The American journal of surgical pathology $x 1532-0979 $g Roč. 47, č. 6 (2023), s. 661-677
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37070739 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230718 $b ABA008
- 991 __
- $a 20230801132852 $b ABA008
- 999 __
- $a ok $b bmc $g 1963538 $s 1197469
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 47 $c 6 $d 661-677 $e 20230418 $i 1532-0979 $m The American journal of surgical pathology $n Am J Surg Pathol $x MED00000304
- LZP __
- $a Pubmed-20230718
